- Advanced drug development for neurodegenerative diseases with α-synuclein Drug Target Review
- Advancing Preclinical Alzheimer Research Through AI and Behavioral Analysis: Stephanie R. Miller, PhD NeurologyLive
- ‘AI+X: AD’ training program brings artificial intelligence to Alzheimer’s research The State Press
- AD/PD™ 2025: Advances in Science & Therapy Alzforum
- AAN 2025: AI’s Promising Role in Cognitive Decline Research and Personalized Medicine Pharmacy Times
